{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:40:08Z","timestamp":1760910008125,"version":"build-2065373602"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.cyto.2020.155405","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T21:51:43Z","timestamp":1608241903000},"page":"155405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Altered plasma levels of \u03b2C and \u03b3C chain cytokines and post-treatment modulation in tuberculous lymphadenitis"],"prefix":"10.1016","volume":"138","author":[{"given":"Gokul Raj","family":"Kathamuthu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadar","family":"Moideen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rathinam","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhanaraj","family":"Baskaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subash","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2020.155405_b0005","unstructured":"WHO Global tuberculosis report, 2019. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis. https:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"issue":"1","key":"10.1016\/j.cyto.2020.155405_b0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3855\/jidc.2090","article-title":"Nodal tuberculosis revisited: a review","volume":"6","author":"Handa","year":"2012","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.cyto.2020.155405_b0015","first-page":"585","article-title":"Tuberculous lymphadenitis","volume":"57","author":"Mohapatra","year":"2009","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/j.cyto.2020.155405_b0020","first-page":"561490","article-title":"Multiplex analysis of pro- or anti-inflammatory serum cytokines and chemokines in relation to gender and age among tanzanian tuberculous lymphadenitis patients","volume":"2015","author":"Mustafa","year":"2015","journal-title":"Tubercul. Res."},{"key":"10.1016\/j.cyto.2020.155405_b0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cyto.2016.10.013","article-title":"Reduced systemic and mycobacterial antigen-stimulated concentrations of IL-1\u03b2 and IL-18 in tuberculous lymphadenitis","volume":"90","author":"Kathamuthu","year":"2017","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.cyto.2020.155405_b0030","doi-asserted-by":"crossref","first-page":"a018424","DOI":"10.1101\/cshperspect.a018424","article-title":"Innate and adaptive cellular immune responses to mycobacterium tuberculosis infection","volume":"5","author":"Mayer-Barber","year":"2015","journal-title":"Cold Spring Harbor Perspectives Med."},{"key":"10.1016\/j.cyto.2020.155405_b0035","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155405_b0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/fvl.12.123","article-title":"HIV-1 and the immune response to TB","volume":"8","author":"Walker","year":"2013","journal-title":"Future Virol."},{"key":"10.1016\/j.cyto.2020.155405_b0045","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","article-title":"The \u03b3c Family of Cytokines: basic biology to therapeutic ramifications","volume":"50","author":"Leonard","year":"2019","journal-title":"Immunity."},{"issue":"4","key":"10.1016\/j.cyto.2020.155405_b0050","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jaci.2003.08.015","article-title":"Biology of common \u03b2 receptor\u2013signaling cytokines IL-3, IL-5, and GM-CSF","volume":"112","author":"Martinez-Moczygemba","year":"2003","journal-title":"J. Allergy. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2020.155405_b0055","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1182\/blood.V88.7.2458.bloodjournal8872458","article-title":"Hematopoiesis in mice lacking the entire granulocyte\u2013macrophage colony-stimulating factor\/interleukin-3\/interleukin-5 functions","volume":"88","author":"Nishinakamura","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cyto.2020.155405_b0060","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.immuni.2019.03.022","article-title":"GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation","volume":"50","author":"Dougan","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cyto.2020.155405_b0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-065X.2012.01164.x","article-title":"The GM-CSF\/IL-3\/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling","volume":"250","author":"Broughton","year":"2012","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.cyto.2020.155405_b0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cyto.2015.02.005","article-title":"The \u03b2c receptor family - structural insights and their functional implications","volume":"74","author":"Broughton","year":"2015","journal-title":"Cytokine."},{"issue":"5","key":"10.1016\/j.cyto.2020.155405_b0075","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.immuni.2016.10.026","article-title":"GM-CSF: from growth factor to central mediator of tissue inflammation","volume":"45","author":"Becher","year":"2016","journal-title":"Immunity."},{"issue":"3","key":"10.1016\/j.cyto.2020.155405_b0080","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1006\/jmbi.1996.0337","article-title":"Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3","volume":"259","author":"Feng","year":"1996","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155405_b0085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/(SICI)1097-0134(199611)26:3<304::AID-PROT6>3.0.CO;2-D","article-title":"Refined crystal structure and mutagenesis of human granulocyte-macrophage colony-stimulating factor","volume":"26","author":"Rozwarski","year":"1996","journal-title":"Proteins"},{"issue":"6425","key":"10.1016\/j.cyto.2020.155405_b0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/363172a0","article-title":"A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5","volume":"363","author":"Milburn","year":"1993","journal-title":"Nat."},{"issue":"10","key":"10.1016\/j.cyto.2020.155405_b0095","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1398-9995.2004.00606.x","article-title":"Human mast cells express receptors for IL-3, IL-5 and GM\u2013CSF: a partial map of receptors on human mast cells cultured in-vitro","volume":"59","author":"Dahl","year":"2004","journal-title":"Allergy"},{"issue":"6671","key":"10.1016\/j.cyto.2020.155405_b0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/32190","article-title":"Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites","volume":"392","author":"Lantz","year":"1998","journal-title":"Nat."},{"issue":"1 Pt 1","key":"10.1016\/j.cyto.2020.155405_b0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0091-6749(90)90229-W","article-title":"Specific binding of human interleukin-3 and granulocyte\u2013macrophage colony-stimulating factor to human basophils","volume":"85","author":"Lopez","year":"1990","journal-title":"J. Allergy. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155405_b0110","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.4049\/jimmunol.0902447","article-title":"Cutting edge: basophils are transiently recruited into the draining lymph nodes during helminth infection via IL-3, but infection- induced Th2 immunity can develop without basophil lymph node recruitment or IL-3","volume":"184","author":"Kim","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155405_b0115","doi-asserted-by":"crossref","unstructured":"K. Takatsu, R. Dickason, D. Huston, Interleukin-5. In LeRoith, ed., Growth Factors and Cytokines in Health and Dis 143. (1997) Vol. IIA. JAI Press Ltd., London.","DOI":"10.1016\/S1874-5687(97)80025-0"},{"issue":"1","key":"10.1016\/j.cyto.2020.155405_b0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1359-6101(97)00034-8","article-title":"Interleukin 5 and B cell differentiation","volume":"9","author":"Takatsu","year":"1998","journal-title":"Cytokines. Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.cyto.2020.155405_b0125","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.4049\/jimmunol.124.5.2414","article-title":"Antigen-induced T cell-replacing factor (TRF). I. Functional characterization of a TRF-producing helper T cell subset and genetic studies on TRF production","volume":"124","author":"Takatsu","year":"1980","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155405_b0130","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3389\/fimmu.2019.02055","article-title":"GM-CSF-dependent inflammatory pathways","volume":"10","author":"Hamilton","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2020.155405_b0135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/248703a0","article-title":"Production of colony-stimulating activity by human lymphocytes","volume":"248","author":"Cline","year":"1974","journal-title":"Nat."},{"issue":"3","key":"10.1016\/j.cyto.2020.155405_b0140","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI107958","article-title":"Release of colony-stimulating activity from thymus-derived lymphocytes","volume":"55","author":"Ruscetti","year":"1975","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cyto.2020.155405_b0145","first-page":"189","article-title":"Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells","volume":"75","author":"Churchill","year":"1992","journal-title":"Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2020.155405_b0150","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1172\/JCI112512","article-title":"Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2","volume":"77","author":"Zucali","year":"1986","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.cyto.2020.155405_b0155","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/ard.2010.146225","article-title":"Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-alpha, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study","volume":"70","author":"Burmester","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.cyto.2020.155405_b0160","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/annrheumdis-2012-202450","article-title":"Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis","volume":"72","author":"Burmester","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.cyto.2020.155405_b0165","article-title":"The \u03b3c family of cytokines: fine-tuning signals from IL-2 and IL-21 in the regulation of the immune response","volume":"23","author":"Spolski","year":"2017","journal-title":"F1000Res."},{"issue":"3","key":"10.1016\/j.cyto.2020.155405_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000300","article-title":"The role of cytokines which signal through the common gamma chain cytokine receptor in the reversal of HIV specific CD4(+) and CD8(+) T cell anergy","volume":"2","author":"Gu","year":"2007","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cyto.2020.155405_b0175","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2249.1995.tb08345.x","article-title":"IL-7 enhancement of antigen- driven activation\/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp)","volume":"101","author":"Ferrari","year":"1995","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155405_b0180","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00281-006-0047-y","article-title":"Cytokine-adjuvanted HIV-DNA vaccination strategies","volume":"28","author":"Lori","year":"2006","journal-title":"Springer. Semin. Immunopathol."},{"key":"10.1016\/j.cyto.2020.155405_b0185","first-page":"861920","article-title":"Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy","volume":"2011","author":"Meazza","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"5598","key":"10.1016\/j.cyto.2020.155405_b0190","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1077002","article-title":"A critical role for IL-21 in regulating immunoglobulin production","volume":"298","author":"Ozaki","year":"2002","journal-title":"Science."},{"key":"10.1016\/j.cyto.2020.155405_b0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2020.155405_b0200","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1128\/IAI.68.5.2962-2970.2000","article-title":"Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice","volume":"68","author":"Maeurer","year":"2000","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.cyto.2020.155405_b0205","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1525-1578(10)60493-X","article-title":"The molecular pathology of primary immunodeficiencies","volume":"6","author":"Lim","year":"2004","journal-title":"J. Mol. Diagn."},{"issue":"8\u20139","key":"10.1016\/j.cyto.2020.155405_b0210","first-page":"751","article-title":"Cytokine therapies in HIV infection","volume":"22","author":"Levy","year":"2006","journal-title":"Med. Sci (Paris)"},{"issue":"12","key":"10.1016\/j.cyto.2020.155405_b0215","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1084\/jem.194.12.1711","article-title":"Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells","volume":"194","author":"Geginat","year":"2001","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cyto.2020.155405_b0220","doi-asserted-by":"crossref","first-page":"e0176495","DOI":"10.1371\/journal.pone.0176495","article-title":"Diminished plasma levels of common \u03b3- chain cytokines in pulmonary tuberculosis and reversal following treatment","volume":"12","author":"Kumar","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2020.155405_b0225","doi-asserted-by":"crossref","first-page":"154929","DOI":"10.1016\/j.cyto.2019.154929","article-title":"Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment","volume":"127","author":"Moideen","year":"2020","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.cyto.2020.155405_b0230","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","article-title":"Predominant TH2- like bronchoalveolar T-lymphocyte population in atopic asthma","volume":"326","author":"Robinson","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2020.155405_b0235","first-page":"219","article-title":"Hypereosinophilia in association with pulmonary tuberculosis in a rural population in south India","volume":"100","author":"Ray","year":"1994","journal-title":"Indian. J. Med. Res."},{"issue":"9","key":"10.1016\/j.cyto.2020.155405_b0240","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1128\/iai.59.9.3009-3014.1991","article-title":"Live but not heat-killed mycobacteria cause rapid chemotaxis of large numbers of eosinophils in vivo and are ingested by the attracted granulocytes","volume":"59","author":"Castro","year":"1991","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.cyto.2020.155405_b0245","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/infdis\/156.6.985","article-title":"Capacity of human neutrophils to kill Mycobacterium tuberculosis","volume":"156","author":"Brown","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2020.155405_b0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cyto.2017.09.027","article-title":"Mycobacterium tuberculosis strains induce strain-specific cytokine and chemokine response in pulmonary epithelial cells","volume":"104","author":"Mvubu","year":"2017","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.cyto.2020.155405_b0255","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/340040","article-title":"Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines","volume":"185","author":"Sato","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.cyto.2020.155405_b0260","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mpat.1999.0345","article-title":"Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria","volume":"28","author":"Beltan","year":"2000","journal-title":"Microb. Pathog."},{"issue":"3","key":"10.1016\/j.cyto.2020.155405_b0265","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-2478(90)90049-V","article-title":"Granulocyte-macrophage colony-stimulating factor restricts growth of tubercle bacilli in human macrophages","volume":"24","author":"Denis","year":"1990","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.cyto.2020.155405_b0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jlb.48.1.67","article-title":"Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex","volume":"48","author":"Bermudez","year":"1990","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155405_b0275","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tube.2007.08.009","article-title":"Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis","volume":"88","author":"Szeliga","year":"2008","journal-title":"Tuberculosis (Edinb)"},{"issue":"6","key":"10.1016\/j.cyto.2020.155405_b0280","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1189\/jlb.1204723","article-title":"Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection","volume":"77","author":"Gonzalez-Juarrero","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2020.155405_b0285","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/IAI.69.2.1127-1133.2001","article-title":"Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis","volume":"69","author":"Gonzalez-Juarrero","year":"2001","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.cyto.2020.155405_b0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2015.05.008","article-title":"The differential expression of IL-4 and IL-13 and its impact on type-2 immunity","volume":"75","author":"Bao","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2020.155405_b0295","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.immunol.26.021607.090357","article-title":"The biology of interleukin-2","volume":"26","author":"Malek","year":"2008","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2020.155405_b0300","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.4049\/jimmunol.132.6.2932","article-title":"Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures","volume":"132","author":"Kelso","year":"1984","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155405_b0305","first-page":"185","article-title":"Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy","volume":"1","author":"Johnson","year":"1995","journal-title":"Cytokines Mol. Ther."},{"issue":"3","key":"10.1016\/j.cyto.2020.155405_b0310","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-3083.2009.02294.x","article-title":"Peripheral immune response in pulmo- nary tuberculosis","volume":"70","author":"Aktas","year":"2009","journal-title":"Scand. J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2020.155405_b0315","doi-asserted-by":"crossref","first-page":"e0152483","DOI":"10.1371\/journal.pone.0152483","article-title":"Combined Analysis of IFN- gamma, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT supernatant is useful for distinguishing active tuberculosis from latent infection","volume":"11","author":"Suzukawa","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.cyto.2020.155405_b0320","doi-asserted-by":"crossref","first-page":"e51338","DOI":"10.1371\/journal.pone.0051338","article-title":"Evaluation of the diagnostic potential of IP-10 and IL- 2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population","volume":"7","author":"Wang","year":"2016","journal-title":"PLoS One."},{"issue":"4","key":"10.1016\/j.cyto.2020.155405_b0325","doi-asserted-by":"crossref","first-page":"17182","DOI":"10.4238\/2015.December.16.18","article-title":"Regulation network of serum cytokines induced by tuberculosis-specific antigens reveals biomarkers for tuberculosis diagnosis","volume":"14","author":"Wei","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"3","key":"10.1016\/j.cyto.2020.155405_b0330","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cyto.2012.12.031","article-title":"Multiplex analysis of cytokines\/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings","volume":"61","author":"Anbarasu","year":"2013","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.cyto.2020.155405_b0335","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nm866","article-title":"Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo","volume":"9","author":"Blattman","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2020.155405_b0340","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ni1179","article-title":"A well-adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2020.155405_b0345","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.clim.2007.09.009","article-title":"IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis","volume":"126","author":"Wu","year":"2008","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2020.155405_b0350","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CVI.00620-13","article-title":"Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children","volume":"21","author":"Hur","year":"2014","journal-title":"Clin. Vaccine. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2020.155405_b0355","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.4049\/jimmunol.171.10.5454","article-title":"Increased CD8+ T cell memory to concurrent infection at the expense of increased erosion of pre-existing memory: the paradoxical role of IL-15","volume":"171","author":"Chapdelaine","year":"2003","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2020.155405_b0360","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4049\/jimmunol.167.2.946","article-title":"Over expression of IL-15 in vivo enhances protection against Mycobacterium bovis bacillus Calmette-Guerin infection via augmentation of NK and T cytotoxic responses","volume":"167","author":"Umemura","year":"2001","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2020.155405_b0365","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1128\/IAI.71.10.6045-6048.2003","article-title":"Interleukin-15 as an immune adjuvant to increase the efficacy of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin vaccination","volume":"71","author":"Umemura","year":"2003","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.cyto.2020.155405_b0370","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tube.2011.02.006","article-title":"Discriminating between latent and active tuberculosis with multiple biomarker responses","volume":"91","author":"Frahm","year":"2011","journal-title":"Tuberculosis (Edinb)"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662030421X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662030421X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:59:15Z","timestamp":1760907555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346662030421X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":74,"alternative-id":["S104346662030421X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155405","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered plasma levels of \u03b2C and \u03b3C chain cytokines and post-treatment modulation in tuberculous lymphadenitis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155405"}}